Cathers; Brian E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cathers; Brian E..The latest application filed is for "antiproliferative compounds and methods of use thereof".

Company Profile

11.10.16

Cathers; Brian E. - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antiproliferative Compounds And Methods Of Use Thereof App 20220280505 - Alexander; Matthew D. ; et al.	2022-09-08
Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases Grant 11,419,861 - Chamberlain , et al. August 23, 2	2022-08-23
Antiproliferative compounds and methods of use thereof Grant 11,241,423 - Cathers , et al. February 8, 2	2022-02-08
Antiproliferative compounds and methods of use thereof Grant 11,185,543 - Alexander , et al. November 30, 2	2021-11-30
Compositions And Methods For Inducing Conformational Changes In Cereblon And Other E3 Ubiquitin Ligases App 20210003557 - Cathers; Brian E. ; et al.	2021-01-07
Compositions And Methods For Inducing Conformational Changes In Cereblon And Other E3 Ubiquitin Ligases App 20210000813 - Chamberlain; Philip ; et al.	2021-01-07
Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases Grant 10,830,762 - Cathers , et al. November 10, 2	2020-11-10
Antiproliferative Compounds And Methods Of Use Thereof App 20200253964 - Kind Code	2020-08-13
Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases Grant 10,668,057 - Chamberlain , et al.	2020-06-02
Antiproliferative Compounds And Methods Of Use Thereof App 20200163948 - Cathers; Brian E. ; et al.	2020-05-28
Antiproliferative Compounds And Methods Of Use Thereof App 20190282567 - Alexander; Matthew D. ; et al.	2019-09-19
Antiproliferative compounds and methods of use thereof Grant 10,357,489 - Alexander , et al. July 23, 2	2019-07-23
Compositions And Methods For Inducing Conformational Changes In Cereblon And Other E3 Ubiquitin Ligases App 20190030019 - Chamberlain; Philip ; et al.	2019-01-31
Compositions And Methods For Inducing Conformational Changes In Cereblon And Other E3 Ubiquitin Ligases App 20190017998 - Cathers; Brian E. ; et al.	2019-01-17
Antiproliferative Compounds And Methods Of Use Thereof App 20190008852 - Alexander; Matthew D. ; et al.	2019-01-10
Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases Grant 10,092,555 - Chamberlain , et al. October 9, 2	2018-10-09
Use Of Biomarkers For Predicting Clinical Sensitivity To Cancer Treatment App 20180267043 - LOPEZ-GIRONA; Antonia ; et al.	2018-09-20
Antiproliferative Compounds And Methods Of Use Thereof App 20180221361 - Cathers; Brian E. ; et al.	2018-08-09
Antiproliferative compounds and methods of use thereof Grant 9,968,596 - Cathers , et al. May 15, 2	2018-05-15
Antiproliferative Compounds And Methods Of Use Thereof App 20180021325 - Cathers; Brian E. ; et al.	2018-01-25
Antiproliferative compounds and methods of use thereof Grant 9,808,451 - Cathers , et al. November 7, 2	2017-11-07
Antiproliferative Compounds And Methods Of Use Thereof App 20170007590 - Cathers; Brian E. ; et al.	2017-01-12
Antiproliferative compounds and methods of use thereof Grant 9,499,514 - Hansen , et al. November 22, 2	2016-11-22
Compositions And Methods For Inducing Conformational Changes In Cereblon And Other E3 Ubiquitin Ligases App 20150374678 - CHAMBERLAIN; Philip ; et al.	2015-12-31
Methods for identifying therapeutic targets for treating infectious disease App 20030130179 - Shepard, H. Michael ; et al.	2003-07-10
Viral enzyme activated prototoxophores and use of same to treat viral infections App 20030114385 - Cathers, Brian E. ; et al.	2003-06-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.